These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 7447291)

  • 1. Measurement of tumor thickness as a prognostic tool in primary malignant melanoma of the skin.
    Dvir E; Gellei B; Hirshowitz B
    Ann Plast Surg; 1980 Sep; 5(3):216-21. PubMed ID: 7447291
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.
    Søndergaard K
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of tumour thickness in cutaneous malignant melanoma.
    Jeffrey I; Royston P; Sowter C; Slavin G; Price A; Pomerance A; Goolamali S; Pinto D
    J Clin Pathol; 1983 Jan; 36(1):51-6. PubMed ID: 6822677
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [1st Stage I melanoma of the limbs. Prognosis on the basis of the depth of invasion and maximum thickness].
    Bresloy A; Kashinelli N; van der Esh ER; Morabito A
    Vopr Onkol; 1980; 26(11):15-21. PubMed ID: 7456419
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Morphological prognostic criteria in skin melanoma].
    Parshikova SM; Khasanov ShR
    Vopr Onkol; 1991; 37(3):283-8. PubMed ID: 2031322
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Primary cutaneous melanoma. Optimized cutoff points of tumor thickness and importance of Clark's level for prognostic classification.
    Büttner P; Garbe C; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
    Cancer; 1995 May; 75(10):2499-2506. PubMed ID: 7736394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Malignant melanoma in life insurance--thickness or anatomic layer?].
    Müller WA; Erlanger M
    Versicherungsmedizin; 1994 Dec; 46(6):193-5. PubMed ID: 7825264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
    Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
    J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malignant melanoma and its therapy: a review.
    Chanda JJ; Callen JP; Stawiski MA
    Cutis; 1979 Jun; 23(6):759-83. PubMed ID: 380931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous malignant melanoma.
    Maize JC
    J Am Acad Dermatol; 1983 Jun; 8(6):857-63. PubMed ID: 6345610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diagnosis, treatment and prognosis of early melanoma. The importance of depth of microinvasion.
    Lee YT
    Ann Surg; 1980 Jan; 191(1):87-97. PubMed ID: 7352783
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the role of CD2 in disease progression and overall survival among patients with completely resected stage-II to -III cutaneous melanoma.
    Harcharik S; Bernardo S; Moskalenko M; Pan M; Sivendran M; Bell H; Hall LD; Castillo-Martín M; Fox K; Cordon-Cardo C; Chang R; Sivendran S; Phelps RG; Saenger Y
    J Am Acad Dermatol; 2014 Jun; 70(6):1036-44. PubMed ID: 24698703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognosis for polypoidal melanoma is determined by primary tumor thickness.
    Reed KM; Bronstein BR; Mihm MC; Sober AJ
    Cancer; 1986 Mar; 57(6):1201-3. PubMed ID: 3943042
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic importance of a second invasive primary melanoma according to tumour stage.
    Youlden DR; Baade PD; Aitken JF; Green AC; Khosrotehrani K
    Br J Dermatol; 2017 Dec; 177(6):e336-e337. PubMed ID: 28771669
    [No Abstract]   [Full Text] [Related]  

  • 15. A study of the thickness of uninvolved dermis beneath cutaneous malignant melanoma: the ratio of uninvolved dermis to tumour thickness (DT:TT) as a prognostic index.
    Saxby PJ; Griffiths RW; Corbishley CM; Briggs JC
    Br J Plast Surg; 1984 Oct; 37(4):496-500. PubMed ID: 6498387
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumor-associated B cells in cutaneous primary melanoma and improved clinical outcome.
    Garg K; Maurer M; Griss J; Brüggen MC; Wolf IH; Wagner C; Willi N; Mertz KD; Wagner SN
    Hum Pathol; 2016 Aug; 54():157-64. PubMed ID: 27107457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor-infiltrating lymphocytes predict sentinel lymph node positivity in patients with cutaneous melanoma.
    Taylor RC; Patel A; Panageas KS; Busam KJ; Brady MS
    J Clin Oncol; 2007 Mar; 25(7):869-75. PubMed ID: 17327608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melanoma prognostic factors found in the dermatopathology report.
    Payette MJ; Katz M; Grant-Kels JM
    Clin Dermatol; 2009; 27(1):53-74. PubMed ID: 19095154
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical course of cutaneous malignant melanoma related to histopathological criteria of primary tumour.
    Drzewiecki KT; Christensen HE; Ladefoged C; Poulsen H
    Scand J Plast Reconstr Surg; 1980; 14(3):229-34. PubMed ID: 7209408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Volume of malignant melanoma is superior to thickness as a prognostic indicator. Preliminary observation.
    Friedman RJ; Rigel DS; Kopf AW; Grin CM; Heilman E; Bart RS; Kamino H; Harris MN; Roses DF; Postel AH
    Dermatol Clin; 1991 Oct; 9(4):643-8. PubMed ID: 1934639
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.